Neomycin Sulphate 0.5%, Beclomethasone Dipropionate 0.025%, Clotrimazole 1.0% & Lignocaine HCl 2.0% Ear Drops — Eye-Ear Drops
WHO-GMP Certified Commercial Pack · Product Code: AKP-067

Neomycin Sulphate 0.5%, Beclomethasone Dipropionate 0.025%, Clotrimazole 1.0% & Lignocaine HCl 2.0% Ear Drops

Formulation Overview: Comprehensive four-in-one antibacterial, antifungal, anti-inflammatory corticosteroid, and local anaesthetic ear drop targeting mixed otomycosis and painful swimmer's ear. Formulated with Neomycin Sulphate 0.5% + Beclomethasone Dipropionate 0.025% + Clotrimazole 1.0% + Lignocaine HCl 2.0% (0.5% + 0.025% + 1.0% + 2.0% w/v) in Sterile Multi-Action Ear Drops dosage form under Ophthalmic & Otic Care, manufactured to IP / BP / USP Compendial standards and supplied in 5 ml / 10 ml Dropper Bottle with Individual Carton with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
Item Code (SKU)AKP-067
Therapeutic SectorOphthalmic & Otic Care
Dosage FormSterile Multi-Action Ear Drops
Active IngredientNeomycin Sulphate 0.5% + Beclomethasone Dipropionate 0.025% + Clotrimazole 1.0% + Lignocaine HCl 2.0%
Strength / Purity0.5% + 0.025% + 1.0% + 2.0% w/v
Clinical IndicationMixed bacterial and fungal otitis externa (otomycosis), ear canal pruritus, edema, and otalgia
Specification StandardIP / BP / USP Compendial
Packaging Format5 ml / 10 ml Dropper Bottle with Individual Carton
Shelf Life24–36 Months
Storage ConditionsStore below 25°C; protect from light; external ear canal use only
Minimum Order Quantity1000 Packs
Regulatory / Analytical DocsFull eCTD / ACTD Modules 1–5 + Zone IVb Stability Available
African & Global NRA ReadinessNAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA
Stock AvailabilityIn Stock · Immediate Commercial Dispatch
Supply StatusCommercial Export Ready

Related Eye-Ear Drops & Ophthalmic & Otic Care